20.06.2011 • Videos

Thomas Gründemann of Ferak Berlin on Custom Synthesis Trends

Ferak Berlin CEO Thomas Grünemann took a few minutes at this year's Chemspec Europe in Geneva to talk to CHEManager Europe Editor-in-Chief Brandi Schuster about custom synthesis and his company's "one product per campaign" strategy.

Company

Ferak Berlin GmbH

Lahnstr. 34
12055 Berlin
Germany

Company contact







Article

The State of the US Specialty Chemicals Industry
Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

Top-Feature

most read